𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer

✍ Scribed by Carolyn Collins; Celestia S. Higano; Robert B. Livingston; Brian R. Griffin; Michael D. Keppen; Thomas P. Miller

Publisher
Springer
Year
1989
Tongue
English
Weight
528 KB
Volume
24
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vincristine, adriamycin, cyclophosphamid
Vincristine, adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung
✍ F. E. Eyben; Γ…. Arwidi; C. Hellekant; K. Jonsson; S. Γ…. Lindahl; W. Mattsson; L. πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 299 KB

Twelve patients with small-cell anaplastic carcinoma of the lung were treated with vincristine 1 mg/m2 i.v. day 1, adriamycin 50 mg/M2 i.v. day 1, cyclophosphamide 1,000 mg/m2 i.v. day 1, and etoposide 80 mg/m2 i.v. day 2, 4, 6 given on an outpatient basis and repeated at 3-week intervals. As consol

Treatment of small cell lung cancer with
Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy
✍ H. CortΓ©s Funes; P. Dominguez; A. Perez Torrubia; E. Lanzos; M. Mendez; C. Mendi πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 505 KB

Fifty five patients with small cell lung cancer with treated with VP16-213 combination chemotherapy regimen in two consecutive series. The first series included 24 patients; 10 with limited and 14 with extensive disease were treated with VP16-213, 120 mg/m2 p.o. daily for 5 consecutive days, Cycloph

Doxorubicin, cyclophosphamide and VP16-2
Doxorubicin, cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer
✍ Joseph Aisner; Margaret Whitacre; David A. VanEcho; Margaret Wesley; Peter H. Wi πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 742 KB

Small cell lung cancer requires aggressive combination chemotherapy. The three active agents, doxorubicin (A) 45 mg/m2 i.v. day 1, cyclophosphamide (C) 1.0 mg/m2 i.v. day 1 and VP16-213 (E) 50 mg/m2/day i.v. days 1-5 were given together. The combination (ACE) was given every 21 days without chest ir